Karine Lacombe

InstitutionSaint-Antoine Hospital
AddressParis
France
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 19 Covid-19 publications, with a maximum of 3 publications in November 2020 and January 2021
    All Publications
    Bar chart showing 152 publications over 20 distinct years, with a maximum of 17 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Richier Q, Plaçais L, Lacombe K, Hermine O. Tocilizumab in Coronavirus Disease 2019: Give It Time! Clin Infect Dis. 2021 12 16; 73(12):2368-2369. PMID: 33515253.
      Citations:    Fields:    Translation:Humans
    2. Martinot M, Jary A, Fafi-Kremer S, Leducq V, Delagreverie H, Garnier M, Pacanowski J, Mékinian A, Pirenne F, Tiberghien P, Calvez V, Humbrecht C, Marcelin AG, Lacombe K. Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019. Clin Infect Dis. 2021 10 05; 73(7):e1762-e1765. PMID: 32986807.
      Citations: 21     Fields:    Translation:HumansCells
    3. Gaborit B, Dailly E, Vanhove B, Josien R, Lacombe K, Dubee V, Ferre V, Brouard S, Ader F, Vibet MA, Le Thuaut A, Danger R, Flet L, Omnes A, Berly L, Chiffoleau A, Jobert A, Duvaux O, Raffi F. Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study. Antimicrob Agents Chemother. 2021 08 17; 65(9):e0123721. PMID: 34181475.
      Citations: 3     Fields:    Translation:HumansAnimalsCTClinical Trials
    4. Pommeret F, Colomba J, Bigenwald C, Laparra A, Bockel S, Bayle A, Michot JM, Hueso T, Albiges L, Tiberghien P, Marot S, Jary A, Lacombe K, Barlesi F, Griscelli F, Colomba E. Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies. Ann Oncol. 2021 11; 32(11):1445-1447. PMID: 34352377.
      Citations: 3     Fields:    Translation:HumansCells
    5. Richier Q, Jachiet V, Bonnemains V, Plaçais L, Abisror N, Garnier M, Pacanowski J, Dhote R, Hinchschberger O, Michel M, Bienvenu B, Comarmond C, Lacombe K, Mekinian A. Tocilizumab and COVID-19: Timing of administration assessment. Infect Dis Now. 2022 Feb; 52(1):31-34. PMID: 34198000.
      Citations:    
    6. Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabié A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, Lê MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837. PMID: 34048876.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    7. Duléry R, Lamure S, Delord M, Di Blasi R, Chauchet A, Hueso T, Rossi C, Drenou B, Deau Fischer B, Soussain C, Feugier P, Noël N, Choquet S, Bologna S, Joly B, Philippe L, Kohn M, Malak S, Fouquet G, Daguindau E, Taoufik Y, Lacombe K, Cartron G, Thiéblemont C, Besson C. Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy. Am J Hematol. 2021 08 01; 96(8):934-944. PMID: 33909916.
      Citations: 13     Fields:    Translation:HumansCells
    8. Gaborit B, Vanhove B, Vibet MA, Le Thuaut A, Lacombe K, Dubee V, Ader F, Ferre V, Vicaut E, Orain J, Le Bras M, Omnes A, Berly L, Jobert A, Morineau-Le Houssine P, Botturi K, Josien R, Flet L, Degauque N, Brouard S, Duvaux O, Poinas A, Raffi F. Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial. Trials. 2021 Mar 09; 22(1):199. PMID: 33750432.
      Citations: 4     Fields:    Translation:HumansAnimalsCTClinical Trials
    9. Garraud O, Lacombe K, Tiberghien P. A look-back at convalescent plasma to treat COVID-19. Transfus Apher Sci. 2021 02; 60(1):103063. PMID: 33478889.
      Citations: 3     Fields:    Translation:Humans
    10. Genthon A, Chiarabini T, Baylac P, Valin N, Urbina T, Pacanowski J, Mekinian A, Brissot E, M 'Hammedi-Bouzina F, Lapusan S, Mohty M, Lacombe K, Ingiliz P. Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy. Leuk Lymphoma. 2021 06; 62(6):1502-1505. PMID: 33416421.
      Citations: 2     Fields:    Translation:Humans
    11. Szwebel TA, Veyer D, Robillard N, Eshagh D, Canoui E, Bruneau T, Contejean A, Azoulay C, Serrano T, Hueso T, Izquierdo L, Rozenberg F, Terrier B, Vignon M, Laurent-Puig P, Taly V, Bélec L, Kernéis S, Lacombe K, Péré H. Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient. Stem Cell Rev Rep. 2021 02; 17(1):296-299. PMID: 33403488.
      Citations: 5     Fields:    Translation:HumansCells
    12. Samer C, Lacombe K, Calmy A. Cyber harassment of female scientists will not be the new norm. Lancet Infect Dis. 2021 04; 21(4):457-458. PMID: 33357516.
      Citations:    Fields:    Translation:Humans
    13. Richier Q, Plaçais L, Lacombe K, Hermine O. [COVID-19: Still a place for tocilizumab?] Rev Med Interne. 2021 02; 42(2):73-78. PMID: 33288230.
      Citations:    Fields:    Translation:HumansPHPublic Health
    14. London J, Boutboul D, Lacombe K, Pirenne F, Heym B, Zeller V, Baudet A, Ouedrani A, Bérezné A. Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy. J Clin Immunol. 2021 02; 41(2):356-361. PMID: 33219491.
      Citations: 7     Fields:    Translation:HumansCells
    15. Hueso T, Pouderoux C, Péré H, Beaumont AL, Raillon LA, Ader F, Chatenoud L, Eshagh D, Szwebel TA, Martinot M, Camou F, Crickx E, Michel M, Mahevas M, Boutboul D, Azoulay E, Joseph A, Hermine O, Rouzaud C, Faguer S, Petua P, Pommeret F, Clerc S, Planquette B, Merabet F, London J, Zeller V, Ghez D, Veyer D, Ouedrani A, Gallian P, Pacanowski J, Mékinian A, Garnier M, Pirenne F, Tiberghien P, Lacombe K. Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19. Blood. 2020 11 12; 136(20):2290-2295. PMID: 32959052.
      Citations: 73     Fields:    Translation:HumansCellsPHPublic Health
    16. Lamure S, Duléry R, Di Blasi R, Chauchet A, Laureana C, Deau-Fischer B, Drenou B, Soussain C, Rossi C, Noël N, Choquet S, Bologna S, Joly B, Kohn M, Malak S, Fouquet G, Daguindau E, Bernard S, Thiéblemont C, Cartron G, Lacombe K, Besson C. Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study. EClinicalMedicine. 2020 Oct; 27:100549. PMID: 33073216.
      Citations: 18     
    17. Gupta N, Desalegn H, Ocama P, Lacombe K, Njouom R, Afihene M, Cunha L, Spearman CW, Sonderup MW, Kateera F. Converging pandemics: implications of COVID-19 for the viral hepatitis response in sub-Saharan Africa. Lancet Gastroenterol Hepatol. 2020 07; 5(7):634-636. PMID: 32553140.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    18. Tiberghien P, de Lamballerie X, Morel P, Gallian P, Lacombe K, Yazdanpanah Y. Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how? Vox Sang. 2020 Aug; 115(6):488-494. PMID: 32240545.
      Citations: 62     Fields:    Translation:HumansPHPublic Health
    Lacombe's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (236)
    Explore
    _
    Co-Authors (227)
    Explore
    _
    Similar People (60)
    Explore
    _